Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]
News [3215]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
EHA 2010: Experts discuss treatment of elderly cancer patients
Prof Gordon McVie, Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario...
EHA 2010: Experts discuss treatment of elderly cancer patients ( Prof Gordon McVie, Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario Boccadoro, Prof Pierre Fenaux )
30 Jun 2010
Results of the multiple myeloma study comparing zoledronic acid to clodronate
Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK
Results of the multiple myeloma study comparing zoledronic acid to clodronate ( Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK )
25 Jun 2010
Progress in myeloma survival rates
Professor Jesús San-Miguel - University Hospital of Salamanca, Spain
Progress in myeloma survival rates ( Professor Jesús San-Miguel - University Hospital of Salamanca, Spain )
25 Jun 2010
The efficacy of bendamustine and rituximab in the treatment of indolent...
Dr Mathias Rummel - University Hospital, Giessen, Germany
The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma diseases ( Dr Mathias Rummel - University Hospital, Giessen, Germany )
25 Jun 2010
Personalised and reduced therapy for Hodgkin's lymphoma
Prof Volker Diehl - University of Cologne, Germany
Personalised and reduced therapy for Hodgkin's lymphoma ( Prof Volker Diehl - University of Cologne, Germany )
16 Apr 2010
Roundtable discussion on the latest advances in multiple myeloma therapy
Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz...
Roundtable discussion on the latest advances in multiple myeloma therapy ( Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig )
2 Mar 2010
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for...
Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center...
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma ( Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, USA )
1 Mar 2010
ASH 2009: New treatments for multiple myeloma
Prof Antonio Palumbo - University of Torino, Italy
ASH 2009: New treatments for multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
1 Mar 2010
ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma
Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain
ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma ( Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain )
1 Mar 2010
ASH 2009: New regimens for elderly multiple myeloma patients
Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
ASH 2009: New regimens for elderly multiple myeloma patients ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
1 Mar 2010
ASH 2009: Tackling polyneuropathy associated with bortezomib
Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands
ASH 2009: Tackling polyneuropathy associated with bortezomib ( Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands )
1 Mar 2010
ASH 2009: Novel agents for multiple myeloma
Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA
ASH 2009: Novel agents for multiple myeloma ( Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA )
1 Mar 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation